Business

Moderna’s unlikely journey to rivaling Big Pharma giants’ valuations

Published

3 years ago

6 August 2021

Moderna’s unlikely journey to rivaling Big Pharma giants’ valuations

Boosted by the COVID vaccine, Moderna’s valuation has now leapfrogged that of well-established Big Pharma giants like Bristol Myers Squibb and Sanofi. Can it last? Read More

Up Next

Fortune is dropping its latest cover as NFTs

Don't Miss

Why delivery services Uber Eats and DoorDash are being reined in

Business

These fast-growing Sun Belt cities suffer from high inflation

Published

3 years ago

4 May 2022

Terry Power

These fast-growing Sun Belt cities suffer from high inflation

U.S. migration hotspots tend to have the highest inflation | Fortune

Business

The U.S. is seizing a $325 million helipad-equipped megayacht in Fiji. The question is which Russian oligarch it belongs to

Published

3 years ago

4 May 2022

Terry Power

Oligarch sanctions: U.S. seizing $325 million megayacht in Fiji. The question is which Russian billionaire it belongs to | Fortune

Business

Investors bank on today’s ‘once-in-a-generation’ Fed hike to be one of several

Published

3 years ago

4 May 2022

Terry Power

Investors bank on today's 'once-in-a-generation' Fed hike to be one of several

Fed rate hike: decision day rattles markets as investors worry that a giant ‘once-in-a-generation’ hike will be one of several this year | Fortune

Vitamin Patches Online

Moderna’s unlikely journey to rivaling Big Pharma giants’ valuations

You may like

Business

These fast-growing Sun Belt cities suffer from high inflation

Business

The U.S. is seizing a $325 million helipad-equipped megayacht in Fiji. The question is which Russian oligarch it belongs to

Business

Investors bank on today’s ‘once-in-a-generation’ Fed hike to be one of several